Trueblood Wealth Management LLC Acquires New Holdings in The Procter & Gamble Company (NYSE:PG)

Trueblood Wealth Management LLC acquired a new stake in The Procter & Gamble Company (NYSE:PGFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 7,711 shares of the company’s stock, valued at approximately $1,130,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of PG. Axiom Financial Strategies LLC increased its stake in Procter & Gamble by 7.0% during the first quarter. Axiom Financial Strategies LLC now owns 1,728 shares of the company’s stock worth $276,000 after purchasing an additional 113 shares during the period. AMI Investment Management Inc. increased its stake in Procter & Gamble by 7.2% during the first quarter. AMI Investment Management Inc. now owns 3,461 shares of the company’s stock worth $529,000 after purchasing an additional 233 shares during the period. LSV Asset Management increased its stake in Procter & Gamble by 5.7% during the first quarter. LSV Asset Management now owns 18,600 shares of the company’s stock worth $2,842,000 after purchasing an additional 1,000 shares during the period. Ergoteles LLC purchased a new stake in Procter & Gamble during the first quarter worth about $3,073,000. Finally, Wsfs Capital Management LLC grew its position in shares of Procter & Gamble by 12.0% during the first quarter. Wsfs Capital Management LLC now owns 4,256 shares of the company’s stock worth $650,000 after buying an additional 455 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the transaction, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the transaction, the chief executive officer now owns 36,845 shares in the company, valued at approximately $5,943,835.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 279,063 shares of company stock valued at $43,187,745. Insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

NYSE:PG traded down $0.36 during trading hours on Thursday, hitting $162.25. The company’s stock had a trading volume of 6,786,346 shares, compared to its average volume of 6,902,504. The business’s 50-day moving average is $158.42 and its two-hundred day moving average is $152.16. The company has a market capitalization of $381.78 billion, a PE ratio of 27.19, a PEG ratio of 3.28 and a beta of 0.44. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.44 and a current ratio of 0.64. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $163.14.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.14. The company had revenue of $21.44 billion for the quarter, compared to analyst estimates of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. Procter & Gamble’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.59 earnings per share. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.45 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Friday, January 19th were paid a $0.9407 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend was Thursday, January 18th. Procter & Gamble’s payout ratio is 62.98%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Raymond James boosted their price objective on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a research report on Thursday, January 18th. Finally, UBS Group boosted their price objective on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $168.41.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.